Targeted therapy: an evolving concept in esophageal adenocarcinoma

Oncology (Williston Park). 2010 Nov 15;24(12):1143, 1146, 1148.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adenocarcinoma / drug therapy*
  • ErbB Receptors / antagonists & inhibitors
  • Esophageal Neoplasms / drug therapy*
  • Hepatocyte Growth Factor / antagonists & inhibitors
  • Humans
  • Receptor, IGF Type 1 / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Vascular Endothelial Growth Factor A
  • Hepatocyte Growth Factor
  • ErbB Receptors
  • Receptor, IGF Type 1